These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20550553)

  • 1. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
    Stagg CJ; Lang B; Best JG; McKnight K; Cavey A; Johansen-Berg H; Vincent A; Palace J
    Epilepsia; 2010 Sep; 51(9):1898-901. PubMed ID: 20550553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study.
    Kwan P; Sills GJ; Kelly K; Butler E; Brodie MJ
    Epilepsy Res; 2000 Dec; 42(2-3):191-5. PubMed ID: 11074191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
    Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
    JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibodies in epilepsy and seizure-associated disorders.
    McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
    Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
    Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
    Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases.
    Monnerie H; Le Roux PD
    Exp Neurol; 2008 Sep; 213(1):145-53. PubMed ID: 18599042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.
    Peltola J; Kulmala P; Isojärvi J; Saiz A; Latvala K; Palmio J; Savola K; Knip M; Keränen T; Graus F
    Neurology; 2000 Jul; 55(1):46-50. PubMed ID: 10891904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy.
    Ribak CE; Harris AB; Vaughn JE; Roberts E
    Science; 1979 Jul; 205(4402):211-4. PubMed ID: 109922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intracellular gamma-aminobutyric acid selectively lowers the level of the larger of two glutamate decarboxylase proteins in cultured GABAergic neurons from rat cerebral cortex.
    Rimvall K; Martin DL
    J Neurochem; 1992 Jan; 58(1):158-66. PubMed ID: 1727428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
    Errichiello L; Perruolo G; Pascarella A; Formisano P; Minetti C; Striano S; Zara F; Striano P
    J Neuroimmunol; 2009 Jun; 211(1-2):120-3. PubMed ID: 19428124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
    Lilleker JB; Biswas V; Mohanraj R
    Seizure; 2014 Sep; 23(8):598-602. PubMed ID: 24836709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rate of glutamic acid decarboxylase 65 (GAD-65) antibodies in chronic epilepsy.
    Tizazu E; Ellis CA; Reichert J; Lancaster E
    Seizure; 2020 Aug; 80():38-41. PubMed ID: 32512284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GAD antibodies in a cohort of neuropsychiatric patients.
    Vinke AM; Schaper FLWVJ; Vlooswijk MCG; Nicolai J; Majoie MHJM; Martinez Martinez P; Hoffmann C; Damoiseaux JGMC; Rouhl RPW
    Epilepsy Behav; 2018 May; 82():25-28. PubMed ID: 29579551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the NR2A/2B subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic acid decarboxylase alteration in cortical GABAergic neurons in vitro.
    Monnerie H; Hsu FC; Coulter DA; Le Roux PD
    Neuroscience; 2010 Dec; 171(4):1075-90. PubMed ID: 20923697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study.
    Aguiar TS; Dantas JR; Cabral DB; Rêgo CCS; Zajdenverg L; Salles GF; Alves-Leon SV; Rodacki M; Lima MA
    Seizure; 2019 Oct; 71():318-321. PubMed ID: 31525611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
    Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
    Dayalu P; Teener JW
    Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.